Search

Your search keyword '"Chakravarty, Dimple"' showing total 216 results

Search Constraints

Start Over You searched for: Author "Chakravarty, Dimple" Remove constraint Author: "Chakravarty, Dimple"
216 results on '"Chakravarty, Dimple"'

Search Results

2. When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level

3. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.

4. Independent blinded validation of an AI-based digital histology classifier for prostate cancer recurrence and metastasis risk prediction.

5. CD8 + T cell targeting of tumor antigens presented by HLA-E

6. MP41-05 LIQUID-BIOPSY BASED NOVEL mRNA GENOMIC TEST FOR EARLY DETECTION, PROGNOSIS AND MONITORING OF PROSTATE CANCER: A MULTICENTER STUDY

7. MP74-10 AI-BASED RISK-STRATIFICATION TOOL PATHOMIQ_PRAD ANALYZES HISTOPATHOLOGY IMAGES TO ACCURATELY PREDICT METASTASIS IN BLACK MEN AND HELPS DISCOVER CANCER DRIVERS

8. Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery

10. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

13. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences

14. Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery

19. Data from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

20. Supplementary Data from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

21. Supplementary Figure from A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

24. When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level

25. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

26. Combined burden and functional impact tests for cancer driver discovery using DriverPower

27. Integrative pathway enrichment analysis of multivariate omics data

28. Pathway and network analysis of more than 2500 whole cancer genomes

29. Divergent mutational processes distinguish hypoxic and normoxic tumours

30. Genomic footprints of activated telomere maintenance mechanisms in cancer

31. A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer

32. Abstract 648: A novel small molecule targeting oncogenic PELP1 demonstrates anti-tumor activity in wild-type and mutant ER-positive breast cancer

33. Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer

34. Harnessing the unique immune biology of cytomegalovirus for cancer immunotherapy

35. Integrative Annotation of Variants from 1092 Humans: Application to Cancer Genomics

36. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

37. Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk

41. Hood Technique for Robotic Radical Prostatectomy—Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates

42. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response

46. Analyses of non-coding somatic drivers in 2,658cancer whole genomes

47. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

48. Integrative pathway enrichment analysis of multivariate omics data

49. Pathway and network analysis of more than 2500 whole cancer genomes

50. Pan-cancer analysis of whole genomes

Catalog

Books, media, physical & digital resources